Medicare adds Alzheimer's screening to routine checkups for seniors
S. 1799 — A bill to amend title XVIII of the Social Security Act to provide for certain cognitive impairment detection in the Medicare annual wellness visit and initial preventative physical examination. · Filed by Shelley Capito (R-WV) · 2 cosponsors · Introduced May 19, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires Medicare to add cognitive impairment screening to two routine preventive visits: the annual wellness visit and the initial preventive physical exam. Doctors must use a screening tool approved by the National Institute on Aging and document results in the patient's medical record, starting January 1, 2026. The goal is early detection of Alzheimer's disease and dementia, which affects millions of older Americans.
Why we flagged it
The bill is a straightforward public health measure that mandates cognitive screening in Medicare preventive visits. It is not a tax provision, appropriation, or deregulation—it is a clinical requirement designed to improve early detection of a major disease affecting millions of seniors.
What the text implies
- Screening mandate may increase downstream diagnostic testing and specialist referrals, raising Medicare costs if not offset by early intervention savings.
- Standardized screening tools may create liability exposure for providers if cognitive impairment is detected but not acted upon or communicated clearly.
- Early detection could increase demand for cognitive-behavioral interventions, memory clinics, and dementia care services, straining capacity in underserved areas.
- Disparate impact potential: bill acknowledges Black and Latino seniors have 1.5–2x higher Alzheimer's rates; screening access depends on Medicare enrollment and provider participation, which may vary by geography and socioeconomic status.
Who it affects
Older Medicare beneficiaries gain access to early cognitive screening at no additional cost during routine visits, enabling earlier diagnosis and care planning. The bill addresses a documented public health crisis (Alzheimer's affects 6.9 million Americans, projected to double by 2060) and may help prevent or delay dementia in up to 40% of cases by identifying modifiable risk factors early.
Who stands to gain
- pharmaceutical companies (Alzheimer's drug manufacturers)
- diagnostic testing labs
- memory care and geriatric specialty clinics
- healthcare IT vendors (EHR documentation systems)
Named in the bill
Medicare, Social Security Act, National Institute on Aging, Alzheimer's disease, dementia, BMY (Bristol Myers Squibb), PFE (Pfizer), JNJ (Johnson & Johnson), GH (Guardant Health), DVA (DaVita)
Where it stands
2 cosponsors: 2 Democrats.
- May 19, 2025 — Introduced · Congress.gov: “Introduced in Senate”
- May 19, 2025 — Referred to Senate Committee on Finance · Congress.gov: “Read twice and referred to the Committee on Finance”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
3 lobbying clients named this bill on 6 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $280,000 in lobbying spend. A filing names 6 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 61% of bills with at least one filing.
Shelley Capito, the sponsor, reported $2,021,591 in PAC receipts in the 2026 cycle.
- Usagainstalzheimers Action — $220,000 on 2 filings
- American Geriatrics Society — $40,000 on 2 filings
- Usagainstalzheimer's — $20,000 on 2 filings
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the full bill text on Jun 10, 2026; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Dec 2025 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Medicare adds Alzheimer's screening to routine checkups for seniors” QuorumCivic. https://share.quorumcivic.app/bill/119/s1799 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.